Troxatyl™ (Cytotoxic Chemotherapeutic)

TERMINATED · PHASE1, PHASE2 · Acute Myelogenous Leukemia

Trial stopped June 2007

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.